Agenda for First In Person RINK Meeting:

Date: Thursday, May 2nd, 2024
Proposed time: 1:00 pm - 6:00 pm EDT

1:00 - 1:15 pm Welcome/Introductions/Review of the Mission & Rules of Engagement: Dave Selewski, MD
Ongoing Studies and Studies Seeking New Centers
1:15 - 1:30 pm Update on Almond: Secondary Analysis of Preterm Erythropoietin Neuroprotection Trial (PENUT) study and WE-ROCK (Shina Menon, MD)
1:30 - 1:50 pm Outcomes after Amnioinfusion for Fetal Renal Failure due to BRA or other severe CAKUT (non RAFT) Shina Menon, MD
1:50 - 2:10 pm "Neurodevelopmental outcomes and engagement with special outpatient support services after neonatal kidney replacement therapy" Melissa Zhou, MD
2:10 - 2:30 pm AWAKEN 2.0/ AKI Follow-up study (Michelle Starr, MD)
2:30 - 2:45 pm Break
Developing studies
2:45 - 2:50 pm Working Groups: Instructions David Selewski, MD
2:50 - 3:30 pm

Working groups developing study ideas from the previous meeting 

  • Outcome of hypertension 
  • Evaluating the association of CAKUT and Hepatoblastoma 
  • Evaluating the incidence of AKI and impact on fluid balance of pre-operative caffeine in neonatal cardiac surgery
  • Do preterm neonatal creatinine's reflect maternal creatinine?
  • Evaluating the incidence and impact of Non-cardiac Post operative AKI in the NICU 
  • Vitamin D in the NICU
3:30 - 3:50 pm Break
Work groups for New Opportunities
4:00 - 5:00 pm Working groups Feedback on study ideas above: Groups may continue to work on previous ideas or develop new ones
5:00 - 5:30 pm Free form: New study ideas
5:30 - 6:00 pm Closing